Protara Therapeutics to Present at Upcoming Virtual Investor Conferences
November 24 2020 - 6:00AM
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage
company developing transformative therapies for the treatment of
cancer and rare diseases with significant unmet needs, today
announced that management will present at two upcoming virtual
investor conferences in December:
- Piper Sandler
32nd Annual Virtual Healthcare Conference
- Evercore ISI
3rd Annual HealthCONx Virtual Conference on Thursday, December 3,
2020 at 12:10pm ET
A webcast of the live Evercore presentation can
be accessed by visiting the Events and Presentations section of the
Company’s website: https://ir.protaratx.com. A replay of the
pre-recorded Piper fireside chat is currently available on the
Company’s website. The webcasts will be archived on the Company’s
website for 90 days following the presentation.
About Protara Therapeutics,
Inc.
Protara is committed to identifying and
advancing transformative therapies for people with cancer and rare
diseases with limited treatment options. Protara’s portfolio
includes its lead program, TARA-002, an investigational cell-based
therapy being developed for the treatment of non-muscle invasive
bladder cancer and lymphatic malformations, and IV Choline
Chloride, an investigational phospholipid substrate replacement
therapy for the treatment of intestinal failure-associated liver
disease. For more information, visit www.protaratx.com.
Company Contact:
Blaine DavisProtara
TherapeuticsBlaine.Davis@protaratx.com646-844-0337
Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Oct 2023 to Oct 2024